-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.7583.92% Upside
Mereo BioPharma Group plc Frequently Asked Questions
-
What analysts cover Mereo BioPharma Group plc?
Mereo BioPharma Group plc has been rated by research analysts at Leerink Partners, Robert W. Baird, Needham, Cantor Fitzgerald in the past 90 days.